Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Wachowiak, R; Till, H; Metzger, R; Bierbach, U; Simon, T; Sattler, B; Aigner, T; Sabri, O; Kluge, R; .
RESIDUAL LYMPH NODE METASTASIS IN STAGE 4 NEUROBLASTOMA-ADVANTAGE OF RADIO-GUIDED SURGERY?.
Pediatr Hematol Oncol. 2010; 27(6):471-475
Doi: 10.3109/08880018.2010.489931
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Till Holger
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Log-term prognosis of children suffering from high-risk neuroblastomas is characterized by a shortened event-free survival, especially if metastases remain after chemotherapy. We report the case of a 3-year-old boy afflicted with a stage 4 neuroblastoma and persistent residual lymph node metastases despite the administration of a various number of treatment modalities. The insertion of a MIBG (metaiodobenzylguanidine) single-photon emission computed tomography (SPECT)-CT and radio-guided surgery implementing a hand held gamma probe finally allowed the exact localization and resection of the suspected lymphatic tissue. As a consequence, the child has been under event-free remission for 20 months. Because study-based knowledge is missing due to the small number of affected patients, individual case reports are helpful to improve future treatment strategies.
- Find related publications in this database (using NLM MeSH Indexing)
- 3-Iodobenzylguanidine - diagnostic use
- Child, Preschool -
- Disease-Free Survival -
- Humans -
- Lymphatic Metastasis -
- Male -
- Neoplasm Staging -
- Neuroblastoma - pathology Neuroblastoma - surgery
- Surgery, Computer-Assisted - methods
- Tomography, Emission-Computed, Single-Photon - methods
- Find related publications in this database (Keywords)
- neuroblastoma
- pediatric oncology
- surgery